Insulet (PODD) Gains from Investment Securities (2010 - 2026)

Insulet has reported Gains from Investment Securities for 17 years, with the latest figure at $15.7 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 25.94% year-over-year to $15.7 million; the trailing twelve-month figure through Mar 2026 stood at $20.4 million (up 25.93% YoY), and the FY2025 full-year result was $25.9 million, changed N/A from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $15.7 million, down from $25.9 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $25.9 million in Q4 2025, with the low at -$22.9 million in Q3 2025.
• Historically, Gains from Investment Securities has averaged $4.1 million across 5 years, with a median of $1.7 million in 2025.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities surged 766.67% — and 2023, when it sank 13000.0%.
• Insulet's Gains from Investment Securities stood at $3.2 million in 2022, then soared by 312.5% to $13.2 million in 2023, then tumbled by 153.03% to -$7.0 million in 2024, then jumped by 470.0% to $25.9 million in 2025, then tumbled by 39.38% to $15.7 million in 2026.
• The last three Gains from Investment Securities figures came in at $15.7 million (Q1 2026), $25.9 million (Q4 2025), and -$22.9 million (Q3 2025), per Business Quant data.